Replies to post #735949 on NorthWest Biotherapeutics Inc (NWBO)

[2B_unknown]

dmb2

" though it is unclear if there was a role played by the BCG shortage in the past Direct development or if NWBO just could not fund it after the manipulators crushed the share price, I suspect more the latter and I would personally not connect Citadel to Merck in company strategic planning to this degree."

Citadel not connected?
Looks connected to me. Isn't Citadel part of the Spoofing Lawsuit and a large stock holder of Merck?

tbu

[sentiment_stocks]

Thank you for your very detailed, well-reasoned thoughts on this matter. :)

[exwannabe]

- The question I would ask is whether NWBO has an alternative ready to go since Direct development is close to resuming

There are 300 million doses a year being manufactured by 2 dozen manufacturers.

There are literally hundreds of ongoing trials using BCG

And approval status of BCG does not matter as it is not being used as a drug, just part of the process. Further, Merck is not the supplier in the UK so switching vendors would be reasonable anyway.

I think there is some way NWBO could procure the minuscule amount of BCG they need for a trial.

[Doc logic]

dmb2,

Excellent post and worth a read and thumbs up from all longs. Thanks for sharing your insights which are much appreciated. Best wishes.